Can end of life care for the pediatric patient suffering with escalating and intractable symptoms be improved?

Related Experiment Videos

Kathleen E Houlahan1, Patricia A Branowicki, Jennifer W Mack

  • 1Hematology/Oncology/Stem Cell Transplant Program, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. kathleen.houlahan@childrens.harvard.edu

Insights

Pediatric cancer patients experiencing severe end-of-life symptoms like pain and agitation can now receive faster comfort care. A new rapid response model improves symptom management for children with cancer.

Area of Science:

  • Pediatric Oncology
  • Palliative Care
  • Quality Improvement

Background:

  • Over 12,000 children are diagnosed with cancer annually, with many experiencing intractable end-of-life symptoms.
  • Symptoms such as escalating pain, dyspnea, and agitation cause significant distress to patients, families, and healthcare teams.
  • Managing these severe symptoms presents a challenge for physicians and nursing staff.

Purpose of the Study:

  • To develop and implement an end-of-life (EOL) rapid response model for pediatric cancer patients.
  • To identify and overcome barriers in providing timely comfort care for escalating symptoms.
  • To improve the management of intractable pain, dyspnea, and agitation in children with cancer.

Main Methods:

  • Created a care model including role clarification, management guidelines, and templated physician orders for rapid opioid titration.
  • Solicited staff feedback on the usability and effectiveness of the developed guidelines and orders.
  • Initiated a retrospective chart review to compare symptom management before and after model implementation.

Main Results:

  • The developed EOL Rapid Response Model of Care was implemented.
  • Physician and nursing staff found the guidelines and templated orders helpful and effective.
  • A retrospective chart review is underway to evaluate the model's impact on symptom management.

Conclusions:

  • The EOL Rapid Response Model of Care provides a structured process for managing escalating symptoms in pediatric cancer patients.
  • The model includes specific guidelines and physician orders to facilitate rapid opioid titration for comfort.
  • This initiative aims to enhance the delivery of effective comfort care at the end of life for children with cancer.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.